Rare diseases
Investigational molecules
Locations
Back to Spain371 clinical trials in Palma, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on Switching to Insulin Glargine 300 U/ml from Insulin Glargine 100 U/ml for Patients with Type 2 Diabetes and Kidney Problems
SpainStudy on the Effectiveness and Safety of Benralizumab with Budesonide and Formoterol in Patients with Eosinophilic Asthma Uncontrolled by Standard Treatment
SpainStudy on Sotagliflozin for Improving Symptoms in Patients with Hypertrophic Cardiomyopathy
SpainStudy on the Effectiveness of Cabotegravir and Rilpivirine for People with HIV-1 Who Have Not Responded Well to Oral Treatment
SpainStudy of Quizartinib with Chemotherapy for Adults with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia
SpainStudy on the Effects of Metformin on Cognitive Function in Patients with Huntington's Disease
SpainStudy on the Safety and Effectiveness of AZD8630 for Adults with Uncontrolled Asthma at Risk of Exacerbations
SpainStudy of Sotatercept for People with Pulmonary Arterial Hypertension
SpainStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
SpainStudy on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer
SpainStudy of Tucatinib and Ado-Trastuzumab Emtansine for Patients with Advanced HER2+ Breast Cancer
SpainStudy of Atezolizumab, Trastuzumab, and Vinorelbine for Patients with Advanced HER2-Positive Breast Cancer
SpainThe busiest research cities in the country
What the registry says about research in the country
The cancer research activity in Palma De Mallorca focuses on improving treatment options for multiple myeloma, relapsed refractory multiple myeloma, acute myeloid leukemia, myelodysplastic syndrome, and advanced non-small cell lung cancer. These studies are designed to assess whether newer therapies can improve disease control and patient outcomes.
Across these trials, researchers are comparing innovative approaches with existing care to better understand how to extend survival and deepen responses.
Clinical trial work in cardiovascular diseases is centered on primary prevention of atherosclerotic cardiovascular disease. The main goal is to see whether new preventive strategies can lower the risk of serious heart and vascular events in people at elevated risk.
These studies aim to strengthen early prevention and support better long-term cardiovascular health.
This research area includes studies in hematologic cancers such as multiple myeloma, relapsed refractory multiple myeloma, acute myeloid leukemia, and myelodysplastic syndrome. The focus is on testing therapies that may improve control of blood-related malignancies and deepen treatment responses.
Investigators are working to refine treatment strategies for patients with difficult-to-treat hematologic conditions.
Trials in nervous system diseases are exploring better ways to prevent and ease chronic postsurgical pain after inguinal hernia repair. The aim is to reduce the chance that short-term surgical pain becomes a lasting problem.
These studies focus on making recovery more comfortable and helping patients return to normal activity more smoothly.
Research in stomatognathic diseases is examining ways to prevent clinically relevant oral bleeding after tooth extraction in patients using direct oral anticoagulants or vitamin K antagonists. The purpose is to improve safety in everyday dental care for people on blood-thinning treatment.
These studies aim to support safer dental procedures without compromising cardiovascular protection.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
